Finance

Lists
EHC:NYSE
Encompass Health Corp
USD 121,67
-0,03%
(-0,040) 1D
USD 121,67
0,00% (0,00)
After hours
Closed: 20 Okt., 16:00:03 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EHC...
Open
USD 122,73
High
USD 123,45
Low
USD 119,77
Mkt. cap
12,00 mjd
Avg. vol.
968,31 k
Volume
0,00
Dividend
0,69%
Quarterly dividend
USD 0,21
Ex-dividend date
01 Okt. 2026
P/E ratio
19,86
52-wk high
USD 129,96
52-wk low
USD 92,77
EPS
USD 6,13
Beta
0,75
Shares outstanding
98,65 m
No. of employees
30 k
Open
USD 122,73
High
USD 123,45
Low
USD 119,77
Mkt. cap
12,00 mjd
Avg. vol.
968,31 k
Volume
0,00
Dividend
0,69%
Quarterly dividend
USD 0,21
Ex-dividend date
01 Okt. 2026
P/E ratio
19,86
52-wk high
USD 129,96
52-wk low
USD 92,77
EPS
USD 6,13
Beta
0,75
Shares outstanding
98,65 m
No. of employees
30 k
News stories
From web sources and news partners
Profile
Encompass Health Corporation, formerly Amcare and HealthSouth, based in Birmingham, Alabama, is the United States's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 173 inpatient rehabilitation hospitals located in 39 states and Puerto Rico. Encompass Health's hospitals focus on providing rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The company operated a home health and hospice business that was spun off as Enhabit in 2022. From 1996 to 2003, executives at the company committed accounting fraud on a large scale, leading to a scandal and financial restructuring. Wikipedia
About Encompass Health Corp
CEOMark J. Tarr
Employees29,7 k
Founded22 Feb. 1984
HeadquartersBirmingham, Alabama, Verenigde State van Amerika
SectorHealth care provider
Analyst ratings
Based on 10 analysts giving stock ratings to EHC in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for EHC in the last 3 months.
Highest
Current USD 121,67
USD 155,00 (+27,39%)
Average
USD 146,78 (+20,64%)
Lowest
USD 140,00 (+15,07%)
Analyst
Recommendation
Action
Price target
Projected
Date
A.J. Rice
UBS
Buy
Maintained
USD 155,00
+27,4%
10/12/2026
Ryan Langston
TD Cowen
Buy
Maintained
USD 140,00
+15,1%
10/02/2026
Andrew Cooper
Raymond James
Buy
Reiterated
USD 150,00
+23,3%
09/28/2026
Pito Chickering
Deutsche Bank
Buy
Maintained
USD 142,00
+16,7%
09/18/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
USD 147,00
+20,8%
09/17/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
USD 140,00
+15,1%
08/11/2026
David S Macdonald
Truist Financial
Buy
Maintained
USD 150,00
+23,3%
08/11/2026
Parker Snure
Raymond James
Buy
Maintained
USD 150,00
+23,3%
08/07/2026
Joanna Gajuk
Bank of America Securities
Buy
Reiterated
USD 153,00
+25,7%
08/06/2026
Andrew Mok CFA
Barclays
Buy
Maintained
USD 144,00
+18,4%
08/06/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
08/05/2026
Unknown Analyst
Stephens
Buy
Reiterated
USD 140,00
+15,1%
05/04/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
USD 150,00
+23,3%
05/01/2026
Next call oor 8 dae
Do. 29 Okt., 16:00
Fiscal period
Q3 2026
- / USD 1,36
Revenue / Est. (USD)
- / 1,60 mjd
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,48 mjd
1,54 mjd
1,59 mjd
1,60 mjd
Cost of goods sold
849,40 m
865,60 m
882,40 m
886,40 m
Cost of revenue
849,40 m
865,60 m
882,40 m
886,40 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
71,00 m
88,20 m
73,40 m
77,30 m
Operating expense
384,50 m
395,60 m
402,60 m
422,60 m
Total operating expenses
1,23 mjd
1,26 mjd
1,28 mjd
1,31 mjd
Operating income
243,60 m
283,40 m
301,60 m
288,40 m
Other non operating income
5,90 m
3,70 m
1,20 m
9,10 m
EBT including unusual items
219,90 m
257,70 m
288,70 m
261,60 m
EBT excluding unusual items
219,90 m
257,70 m
271,40 m
264,80 m
Income tax expense
44,90 m
55,40 m
56,40 m
53,60 m
Effective tax rate
20,42%
21,50%
19,54%
20,49%
Other operating expenses
231,10 m
221,00 m
241,90 m
254,90 m
Net income
126,50 m
146,10 m
194,50 m
153,90 m
Net profit margin
8,56%
9,46%
12,26%
9,63%
Earnings per share
1,23
1,46
1,60
1,55
Interest and investment income
-
-
-
-
Interest expense
-30,80 m
-30,20 m
-31,80 m
-32,80 m
Net interest expenses
-30,80 m
-30,20 m
-31,80 m
-32,80 m
Depreciation and amortization charges
82,40 m
86,40 m
87,30 m
90,40 m
EBITDA
326,00 m
369,80 m
388,90 m
378,80 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme